We are live on ! Find out more
SCM

Silverarc Capital Management Portfolio holdings

AUM $980M
1-Year Est. Return 470.8%
This Fund
S&P 500
This Quarter Est. Return
+56.43%
1 Year Est. Return
+470.8%
3 Year Est. Return
+3,352.06%
5 Year Est. Return
+7,957.7%
10 Year Est. Return
–
AUM
$172M
AUM Growth
–
Cap. Flow
+$152M
Cap. Flow %
88.14%
Top 10 Hldgs %
34.38%
Holding
84
New
84
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$6.7M
2
INSM icon
Insmed
INSM
+$6.39M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$5.26M
4
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
+$5.25M
5
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$5.01M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 87.83%
2 Financials 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTX
76
DELISTED
Aptinyx Inc. Common Stock
APTX
$372K 0.22%
+107,536
New +$375K
MRSN
77
DELISTED
Mersana Therapeutics
MRSN
$286K 0.17%
+431
New +$240K
CGEN icon
78
CALL
Compugen
CGEN
$222M
$242K 0.14%
+20,000
New +$276K
ARQT icon
79
Arcutis Biotherapeutics
ARQT
$3.36B
$239K 0.14%
+8,505
New +$208K
FULC icon
80
Fulcrum Therapeutics
FULC
$273M
$190K 0.11%
+16,209
New +$183K
PHGE icon
81
BiomX
PHGE
$1.99M
$88K 0.05%
+72
New +$83.4K
CALA
82
DELISTED
Calithera Biosciences, Inc
CALA
$74K 0.04%
+750
New +$65.7K
CHAQ.WS
83
DELISTED
Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
CHAQ.WS
$49K 0.03%
+98,756
New +$74.7K
BNGOW
84
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
$21K 0.01%
+10,000
New +$2.64K
1 2 3
4

Similar funds

BIP
Blueprint Investment Partners Greensboro, North Carolina $980M AUM 27.19% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $977M AUM 19.09% 1-Year Est. Return
FCM
Fortis Capital Management Bellevue, Washington $977M AUM 17.17% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
GFP
Gryphon Financial Partners Columbus, Ohio $976M AUM 23.05% 1-Year Est. Return
ADIC
Abu Dhabi Investment Council Abu Dhabi, United Arab Emirates $975M AUM
PCM
Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return

Silverarc Capital Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Silverarc Capital Management, which disclosed 84 positions worth $172M. Its ten largest holdings account for 34% of the portfolio.

Its largest position is Vericel Corp: 281,346 shares worth $8.69M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, followed by Financials.

  • Silverarc Capital Management's largest Q4 2020 buy was Vericel Corp: 281,346 shares worth $8.69M.
  • Silverarc Capital Management's ten largest holdings make up 34% of its $172M portfolio in Q4 2020.
  • Silverarc Capital Management disclosed 84 positions in Q4 2020, its first 13F filing on record.

Based on Silverarc Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.